Overview

Expanded access is currently available for this treatment.

Conditions abdominal aortic aneurysms, aorto-iliac aneurysms, juxtarenal aneurysms
Treatment zenith® fenestrated aaa endovascular graft
Sponsor Cook
Start date May 2010
End date November 2012
Trial identifier NCT02577562, 04-541 CA

Summary

The Zenith®Fenestrated AAA Endovascular Graft Clinical Study is a clinical investigation approved by the US FDA to study the safety and effectiveness of the Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic and aorto-iliac aneurysms.

United States No locations recruiting
Other Countries No locations recruiting

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Abdominal aortic and aortoiliac aneurysms with diameter greater than or equal to 5 cm Exclusion Criteria: - Proximal neck less than 4 mm or greater than or equal to 15 mm in length unless otherwise compromised to preclude seal - Renal artery stenosis greater than 50 percent

Additional Information

Official title Zenith® Fenestrated AAA Endovascular Graft Clinical Study
Trial information was received from ClinicalTrials.gov and was last updated in November 2016.
Information provided to ClinicalTrials.gov by Cook.